AzTrials
AzTrials

StrokeMOTIF-STROKENCT07339813

Understanding Motor Function in Stroke Patients and Their Functional Brain Reorganization Using Ultra High-field MRI

A study testing Functional MRI (fMRI) Acquisition in people with Stroke, run by Commissariat A L'energie Atomique at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The MOTIF-STROKE study is embedded within the BrainSync project, aiming to develop innovative strategies for motor rehabilitation of the upper limb. The primary goal is to construct a high-resolution anatomo-functional disconnection atlas in a cohort of 100 stroke patients, using cutting-edge 3T and 7T MRI. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Stroke
What is being tested?
Functional MRI (fMRI) Acquisition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteFrance
Study dates
10 Dec 2025to Jan 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients
  • 1-MRI-confirmed diagnosis of a first ischemic stroke occurring more than 6 months prior to inclusion.
  • 2-Persistent upper-limb motor deficit resulting from the stroke.
  • 3-Absence of significant cognitive impairment: MMSE score ≥ 27 assessed as part of clinical care.
  • 4-Age between 18 and 70 years.
  • 5-Validation by the inclusion validation committee.
Show all 11Show fewer
  • 6-Signed informed consent after clear and fair information about the study.
  • Healthy volunteers:
  • 1-Age between 18 and 70 years.
  • 2-No history of neurological or psychiatric disease.
  • 3-Signed informed consent after clear and fair information about the study.

Who cannot join

  • Patients:
  • 1-Recurrent stroke.
  • 2-Severe aphasia or severe speech disorders preventing adequate interaction for the protocol.
  • 3-Severe auditory or visual impairment.
  • 4-Disorders of comprehension, attention, or neglect affecting understanding of study motor tasks.
  • 5-Associated conditions with an estimated life expectancy of less than 2 years.
Show all 17Show fewer
  • 6-History of brain surgery, craniectomy, or cranioplasty.
  • 7-Other causes of motor disability.
  • 8-Alcohol consumption the day before or on the day of the examination, or use of illicit psychotropic substances within 48 hours prior to MRI.
  • 9-Absolute contraindications to MRI, including pregnancy; intracorporeal metallic foreign bodies; pacemakers; non-MRI-compatible neurostimulators; cochlear implants; implanted medical devices (electronic or non-electronic) implanted for less than 6 weeks; metallic heart valves; stents, coils, carotid or neurosurgical clips; implantable ports; infusion pumps; non-removable piercings; tattoos or permanent makeup larger than 5 cm on the head, neck, trunk, or upper limbs; transdermal devices with metallic components; intrauterine devices (except Mirena); dental appliances larger than 4 cm; or health conditions incompatible with MRI comfort and safety (e.g., acute respiratory or cardiac failure, inability to remain supine, bedridden state, claustrophobia).
  • 10-Individuals not covered by a social security system.
  • 11-Individuals under enhanced protection, including pregnant or breastfeeding women, persons deprived of liberty, legally protected adults, or patients in emergency situations.
  • 12-Pregnant or breastfeeding women, or women of childbearing potential refusing a pregnancy test.
  • Healthy volunteer:
  • 1-Absolute contraindications to MRI as listed above.
  • 2-Individuals not covered by a social security system.
  • 3-Individuals under enhanced protection, including pregnant or breastfeeding women, persons deprived of liberty, legally protected adults, or patients in emergency situations.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wissam ZAMOUN, ARC contact

+33 01.69.08.74.60

wissam.zamoum@cea.fr

France1 site, 1 recruiting
  • NeuroSpin, CEA

    Gif-sur-Yvette, Île-de-France Region, 91191

    Wissam ZAMOUN, +33 01.69.08.74.60, wissam.zamoum@cea.fr

    Myriam EDJLALI-GOUJON, MD, PhD

    Recruiting

Other trials in France

About this study

Official title: Understanding Motor Function in Stroke Patients and Their Functional Brain Reorganization Using Ultra High-field MRI (MOTF-STROKE)

The MOTIF-STROKE study is embedded within the BrainSync project, aiming to develop innovative strategies for motor rehabilitation of the upper limb. The primary goal is to construct a high-resolution anatomo-functional disconnection atlas in a cohort of 100 stroke patients, using cutting-edge 3T and 7T MRI. Data acquisition, commencing in Fall 2025, will combine morphological (T1-weighted), functional and diffusion-weighted MRI scans to perform morphometry, functional and structural connectivity analyses with biomarkers of motor deficits. This atlas seeks to correlate connectivity with motor tasks, using dedicated task-related fMRI paradigms and digital consultation tools. The project utilizes machine learning algorithms and functional hyper-alignment to analyze fMRI data, focusing on input features and their impact on prediction accuracy. The ultimate objective is to optimize implantation of WIMAGINE neuroprostheses for the subsequent BCI4STROKE clinical trial. Expected results include identifying clinical subgroups responsive to motor intention decoding, characterizing phenotypes of functional reorganization, and making the 3D brain atlas accessible to the neuroscience community.

Conditions
Stroke
Being tested
Functional MRI (fMRI) Acquisition
Keywords
motor disability, functionnal MRI, High-field MRI, disconnection atlas, diffusion-weighted MRI, machine learning algorithms
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Functional MRI (fMRI) AcquisitionOther

    Participants undergo task-based and resting-state fMRI sessions, including motor imagery and motor execution tasks. Brain activity and clinical data are collected for analysis.

Study groups in NCT07339813
Study groupRoleWhat they receive
Chronic-Phase Ischemic Stroke Patients and Healthy Volunteer OptimizationOtherParticipants undergo task-based and resting-state fMRI sessions. Imaging and clinical data are collected and analyzed using artificial intelligence models.
Receives: Other: Functional MRI (fMRI) Acquisition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prediction accuracy of AI models for individual motor action intention

    Validation of AI model predictions based on post-processing of functional MRI signals will be performed by comparing them with observed clinical performance during intentional motor tasks. These include assessment of movement intention of the hand and foot, intended movement direction, pathological side, and healthy side.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start10 Dec 2025
  3. Primary completionNov 2027 (estimated)
  4. Study completionJan 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
RIPH 2
Masking
None (open label)
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07339813
Sponsor's protocol ID
CEA 100 077
Acronym
MOTIF-STROKE
Status last verified
Dec 2025
First submitted
5 Jan 2026
Last updated
14 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Functional MRI (fMRI) Acquisition in people with Stroke, run by Commissariat A L'energie Atomique at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wissam ZAMOUN, ARC (+33 01.69.08.74.60, wissam.zamoum@cea.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prediction accuracy of AI models for individual motor action intention (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
MOTIF-STROKE Clinical Trial NCT07339813 | AzTrials